Red blood cell ATP export and transfusion in sepsis

Active Project Grant Awarded Last action

Award ID
R01HL161071
Recipient
Awarding agency
Obligated
$8,890,911

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 96% complete
Place of performance
Durham, NC 27710, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
O2 uptake in the lung and O2 delivery peripherally depend on the efficient matching of blood flow to regional O2 availability in the lung and O2 consumption in tissues. To achieve this matching, red blood cell (RBC) hemoglobin allostery regulates not only trans-erythrocytic O2 flux but also RBC export of vasoactive mediators that respond to O2 demand. Rbcs export vasoregulatory ATP basally and in response to O2 deficit. This RBC-based vascular control of the uptake and delivery of O2 may be disrupted by endogenous (e.g., in sepsis) and exogenous (via storage for transfusion) RBC injuries. Septic persons with moderate anemia are frequently transfused, but infrequently benefit. Yet conversely any anemia is a negative risk factor. Lung morbidity is frequent after RBC transfusion, possibly due to impaired RBC ability to export ATP, disrupting O2 uptake via pulmonary RBC- endothelial adhesion. We show in septic mice (cecal ligation/puncture, CLP) that the RBC's ability to produce and export ATP is impaired. We will test the hypothesis that the O2-transport dysfunction in sepsis is mediated in part by impaired export by rbcs of vasoregulatory ATP, a dysfunction compounded by transfused rbcs, exacerbating acute lung injury (ALI) and hypoxemia, by achieving these aims: aim 1. Determine the role of RBC ATP export in mortality and ALI in a mouse model of sepsis and transfusion. Exchange transfusion of CLP rbcs into healthy mice exposed to hypoxia drives mortality. RBC ATP export takes place via pannexin 1 (PX1). We will determine the role and mechanism of depressed RBC ATP export via PX1 in the mortality, ALI, and O2 transport responses to sepsis (CLP or severe influenza) and transfusion in mice using genetic and pharmacological approaches. Aim 2. Determine the influence of augmenting transfusate RBC ATP content and/or export on organ function and O2 transport in septic mice. RBC ATP export can be augmented via clinically available approaches: hypoxic RBC storage; transfusate incubation with pipa (phosphate, inosine, pyruvate, adenine) solution that preserves stored-RBC ATP and DPG; or using an activator of RBC pyruvate kinase (PKR), which augments RBC ATP with little effect on DPG or P50. We will test these approaches to augment or preserve RBC ATP content on ATP export in mice transfused during sepsis. Aim 3. Determine the influence of human sepsis on RBC vasoregulatory function EX vivo, and the functional influence of candidate modulators of ATP content and export in septic rbcs. We validated a novel RBC cryopreservation scheme with superior phenotype fidelity. We built a unique biobank of RBC specimens from septic children and adults. We prospectively sampled over 150 patients with severe sepsis; most subjects have ALI. We will determine the influence of translation-ready lead candidates identified in aim 2 to augment RBC ATP export on key RBC respiratory functions: vasoactivity, anti-adhesivity, and O2 transport. We will model the effects of transfusate intervention in admixed septic and stored rbcs. Our novel focus on disrupted signaling by rbcs will produce novel, practical, and relevant insight into respiratory dysfunction in sepsis and transfusion.

Transactions

Action Obligated Date
Amendment $19,884
Amendment $629,681
Amendment $629,681
Amendment $67,716
Amendment $67,716
Amendment $67,716
Amendment $0
Amendment $0
Amendment $609,442
Amendment $609,442
Amendment $609,442
Amendment $55,301
Amendment $55,301
Amendment $55,301
Amendment $622,149
Amendment $622,149
Amendment $622,149
Amendment $622,149
Amendment $0
Amendment $0
Amendment $0
Amendment $731,423
Amendment $731,423
Amendment $731,423
Original award $731,423
Show all 25

Subawards

Subrecipient Amount Awarded
University Of Maryland, Baltimore Aim 1. Determine the role of RBC ATP export in mortality and lung injury in a murine sepsis model. We will determine the role of the RBC ATP-export conduit… $943,836
New Health Sciences, Inc. Dr. Yoshida and the Hemanext team will both prepare hypoxically stored, deidentified human RBC units and will also train the Duke team in their preparation.… $69,334

Quick answers

Who received award R01HL161071?

R01HL161071 was awarded to Duke University by National Heart Lung and Blood Institute (National Institutes of Health) on March 5, 2023.

How much is award R01HL161071 worth?

$8,890,911 has been obligated on R01HL161071.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login